This federal contract award, with ID SPE2DE20D0027|SPE2DE21F0037, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of BinaxNOW COVID-19 antigen cards, a type of diagnostic testing product, to support the government's Coronavirus COVID-19 response. The contract has a ceiling value of $15,192.97 and a completion date of October 28, 2020. It is a firm fixed-price delivery order contract, without any set-aside designation. Abbott Rapid DX North America LLC, a for-profit medical diagnostic company, has received multiple contract awards from the DLA and other federal agencies to supply COVID-19 testing supplies and related medical products. The parent company, Abbott Laboratories, is a global healthcare conglomerate that provides a diverse range of medical technologies, devices, and services to various government agencies, particularly the Department of Veterans Affairs and Department of Defense.